STOCK TITAN

LB Pharmaceuticals: Commodore reports 5.8% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

LB Pharmaceuticals Inc. (LBRX) is the subject of an amended beneficial-ownership report in which Commodore Capital LP, Commodore Capital Master LP, Michael Kramarz and Robert Egen Atkinson each report the same aggregate 1,897,745 shares, or 5.8% of the class. The reported total comprises 1,282,273 common shares and 615,472 shares issuable upon exercise of pre-funded warrants; the warrants are subject to a 9.99% beneficial ownership limitation.

Commodore Capital LP is the investment manager to Commodore Capital Master LP. Michael Kramarz and Robert Egen Atkinson are managing partners of the firm and exercise investment discretion over the securities. The ownership percentage is based on 32,269,691 shares reported as issued and outstanding as of September 30, 2026, plus the 615,472 warrant shares.

Beneficially owned shares 1,897,745 shares The same aggregate amount is reported by each of the four reporting persons.
Common shares 1,282,273 shares Part of the reported beneficial-ownership amount.
Shares issuable upon warrant exercise 615,472 shares Part of the reported beneficial-ownership amount; subject to a 9.99% beneficial ownership limitation.
Percentage of class 5.8% Reported by each reporting person.
Shares issued and outstanding 32,269,691 shares Reported as of September 30, 2026; used in the ownership-percentage calculation along with warrant shares.
Beneficial ownership limitation 9.99% Applies to the pre-funded warrants.
pre-funded warrants financial
"615,472 shares of Common Stock issuable upon exercise of pre-funded warrants"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Beneficial Ownership Limitation regulatory
"subject to a beneficial ownership limitation of 9.99%"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
shared voting power regulatory
"shared voting power over 1,897,745 shares"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
investment discretion technical
"exercise investment discretion with respect to these securities"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LBRX shares are reported as beneficially owned?

The four reporting persons each report the same aggregate of 1,897,745 shares, representing 5.8% of the class; these are not four separate reported positions.

How is the reported LBRX ownership percentage calculated?

The reported 5.8% is based on 32,269,691 shares reported as issued and outstanding as of September 30, 2026, plus 615,472 shares issuable upon exercise of pre-funded warrants.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





50180M108

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Commodore Capital LP
Signature:Michael Kramarz
Name/Title:Managing Partner
Date:11/16/2026
Commodore Capital Master LP
Signature:Michael Kramarz
Name/Title:Authorized Signatory
Date:11/16/2026
Robert Egen Atkinson
Signature:Robert Egen Atkinson
Name/Title:Authorized Signatory
Date:11/16/2026
Michael Kramarz
Signature:Michael Kramarz
Name/Title:Authorized Signatory
Date:11/16/2026
Exhibit Information

Exhibit 1: Joint Filing Agreement

Keep reading